Martin Friede

3.6k total citations · 1 hit paper
52 papers, 2.6k citations indexed

About

Martin Friede is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Martin Friede has authored 52 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Infectious Diseases, 24 papers in Epidemiology and 13 papers in Molecular Biology. Recurrent topics in Martin Friede's work include Influenza Virus Research Studies (16 papers), Vaccine Coverage and Hesitancy (11 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Martin Friede is often cited by papers focused on Influenza Virus Research Studies (16 papers), Vaccine Coverage and Hesitancy (11 papers) and SARS-CoV-2 and COVID-19 Research (7 papers). Martin Friede collaborates with scholars based in Switzerland, United States and France. Martin Friede's co-authors include Steven G. Reed, Rhea N. Coler, Sylvie Bertholet, Christopher B. Fox, Marie Paule Kiény, Darrick Carter, Zarifah Reed, Thomas S. Vedvick, Marc Girard and Jean‐Paul Briand and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Advanced Drug Delivery Reviews.

In The Last Decade

Martin Friede

51 papers receiving 2.4k citations

Hit Papers

New horizons in adjuvants for vaccine development 2008 2026 2014 2020 2008 100 200 300 400 500
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. New horizons in adjuvants for vaccine development
    2008 502 citations Steven G. Reed, Sylvie Bertholet et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Martin Friede Switzerland 26 954 848 656 653 386 52 2.6k
Wilbur H. Chen United States 27 828 0.9× 1.0k 1.2× 521 0.8× 1.3k 2.0× 175 0.5× 86 2.9k
Louis Fries United States 37 1.1k 1.1× 1.8k 2.1× 568 0.9× 1.1k 1.7× 500 1.3× 77 3.5k
Donata Medaglini Italy 30 1.1k 1.2× 455 0.5× 879 1.3× 1.1k 1.6× 207 0.5× 97 2.9k
William C. Weldon United States 35 525 0.6× 833 1.0× 448 0.7× 1.4k 2.1× 192 0.5× 105 3.4k
Nigel Temperton United Kingdom 33 961 1.0× 1.9k 2.3× 736 1.1× 1.8k 2.8× 305 0.8× 124 3.9k
Rob Lambkin‐Williams United Kingdom 31 1.1k 1.2× 3.1k 3.6× 1.0k 1.6× 1.4k 2.1× 195 0.5× 74 4.5k
Emanuele Montomoli Italy 38 1.3k 1.4× 2.8k 3.3× 940 1.4× 2.1k 3.2× 306 0.8× 210 5.1k
Nathalie Garçon Belgium 34 2.8k 3.0× 1.7k 2.1× 1.7k 2.5× 1.3k 1.9× 991 2.6× 67 5.3k
Rebecca Jane Cox Norway 35 2.0k 2.1× 3.0k 3.6× 633 1.0× 1.4k 2.1× 91 0.2× 158 4.4k
Shital M. Patel United States 21 379 0.4× 1.0k 1.2× 418 0.6× 628 1.0× 357 0.9× 60 1.9k

Countries citing papers authored by Martin Friede

Since Specialization
Citations

This map shows the geographic impact of Martin Friede's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Martin Friede with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Martin Friede more than expected).

Fields of papers citing papers by Martin Friede

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Martin Friede. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Martin Friede. The network helps show where Martin Friede may publish in the future.

Co-authorship network of co-authors of Martin Friede

This figure shows the co-authorship network connecting the top 25 collaborators of Martin Friede. A scholar is included among the top collaborators of Martin Friede based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Martin Friede. Martin Friede is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Giersing, Birgitte, Annie X. Mo, Shahida Baqar, et al.. (2025). Meeting summary: Global vaccine and immunization research forum, 2023. Vaccine. 46. 126686–126686. 2 indexed citations
2.
3.
Trotter, Caroline, Birgitte Giersing, Ann Lindstrand, et al.. (2024). A Practical Guide to Full Value of Vaccine Assessments. Vaccines. 12(2). 201–201. 5 indexed citations
4.
5.
Zuber, Patrick, et al.. (2021). Evolving pharmacovigilance requirements with novel vaccines and vaccine components. BMJ Global Health. 6(Suppl 2). e003403–e003403. 12 indexed citations
6.
7.
Ostrowsky, Julie, Kristine A. Moore, Michael T. Osterholm, et al.. (2020). Tracking progress in universal influenza vaccine development. Current Opinion in Virology. 40. 28–36. 22 indexed citations
8.
Vekemans, Johan, Nebiat Gebreselassie, Matteo Zignol, et al.. (2019). A new tuberculosis vaccine: breakthrough, challenges, and a call for collaboration. The Lancet Infectious Diseases. 19(2). 123–125. 6 indexed citations
9.
Vekemans, Johan, Vasee Moorthy, Martin Friede, et al.. (2018). Maternal immunization against Group B streptococcus: World Health Organization research and development technological roadmap and preferred product characteristics. Vaccine. 37(50). 7391–7393. 46 indexed citations
10.
Cernuschi, Tania, et al.. (2017). Bacillus Calmette-Guérin (BCG) vaccine: A global assessment of demand and supply balance. Vaccine. 36(4). 498–506. 84 indexed citations
11.
Coler, Rhea N., Sylvie Bertholet, Magdalini Moutaftsi, et al.. (2011). Development and Characterization of Synthetic Glucopyranosyl Lipid Adjuvant System as a Vaccine Adjuvant. PLoS ONE. 6(1). e16333–e16333. 250 indexed citations
12.
Resik, Sonia, Alina Tejeda, Pedro Más Lago, et al.. (2010). Randomized Controlled Clinical Trial of Fractional Doses of Inactivated Poliovirus Vaccine Administered Intradermally by Needle‐Free Device in Cuba. The Journal of Infectious Diseases. 201(9). 1344–1352. 110 indexed citations
13.
Fox, Christopher B., Martin Friede, Steven G. Reed, & Gregory C. Ireton. (2010). Synthetic and Natural TLR4 Agonists as Safe and Effective Vaccine Adjuvants. Sub-cellular biochemistry. 53. 303–321. 51 indexed citations
14.
Eichelberger, Maryna C., Hana Golding, Maureen A. Hess, et al.. (2008). FDA/NIH/WHO public workshop on immune correlates of protection against influenza A viruses in support of pandemic vaccine development, Bethesda, Maryland, US, December 10–11, 2007. Vaccine. 26(34). 4299–4303. 80 indexed citations
15.
Reed, Zarifah, Marie Paule Kiény, Howard Engers, et al.. (2008). Comparison of immunogenicity of five MSP1-based malaria vaccine candidate antigens in rabbits. Vaccine. 27(10). 1651–1660. 26 indexed citations
16.
Etchart, Nathalie, Anà Hennino, Martin Friede, et al.. (2007). Safety and efficacy of transcutaneous vaccination using a patch with the live-attenuated measles vaccine in humans. Vaccine. 25(39-40). 6891–6899. 41 indexed citations
17.
Girard, Marc, Zarifah Reed, Martin Friede, & Marie Paule Kiény. (2006). A review of human vaccine research and development: Malaria. Vaccine. 25(9). 1567–1580. 107 indexed citations
18.
Friede, Martin, et al.. (2004). Need for new vaccine formulations and potential of particulate antigen and DNA delivery systems. Advanced Drug Delivery Reviews. 57(3). 325–331. 50 indexed citations
19.
Pfaffenrath, V., HC Diener, Michael B. Fischer, Martin Friede, & Hans‐Heinrich Henneicke‐von Zepelin. (2002). The Efficacy and Safety of Tanacetum Parthenium (Feverfew) in Migraine Prophylaxis—a Double-Blind, Multicentre, Randomized Placebo-Controlled Dose-Response Study. Cephalalgia. 22(7). 523–532. 125 indexed citations
20.
Friede, Martin, Sylviane Muller, J.-P. Briand, et al.. (1994). Selective induction of protection against influenza virus infection in mice by a lipid—peptide conjugate delivered in liposomes. Vaccine. 12(9). 791–797. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wilbur H. Chen Breakdown of academic impact, for papers by Louis Fries Breakdown of academic impact, for papers by Donata Medaglini Breakdown of academic impact, for papers by William C. Weldon Breakdown of academic impact, for papers by Nigel Temperton Breakdown of academic impact, for papers by Rob Lambkin‐Williams Breakdown of academic impact, for papers by Emanuele Montomoli Breakdown of academic impact, for papers by Nathalie Garçon Breakdown of academic impact, for papers by Rebecca Jane Cox Breakdown of academic impact, for papers by Shital M. Patel
Rankless by CCL
2026